study_id,author,first_dose_only,location_id,location_id2,location_name,location_name2,vac_before_booster,vaccine_developer,variant,symptom_severity,severity,sample_size,age_start,age_end,efficacy_mean,efficacy_lower,efficacy_upper,booster,vemt,mean_time_since_vaccination,start_interval,end_interval,sev_severity,mid_point1,mid_point,study_id2,e_mean,se,mean_logit,sd_logit,in_var
505,Puranik A,0,102,102,United States,USA Mayo Clinic mixed hosp,"",Pfizer & BioNTech,Alpha,severe,hosp,,18,85,0.89,0.18,0.9974,0,0,,9,12,severe,10.5,10.5,505&USA Mayo Clinic mixed hosp&Alpha&hosp&18&85,0.79,0.208520408163265,1.3249254147436,1.25690420833795,0.218990722699236
505,Puranik A,0,102,102,United States,USA Mayo Clinic mixed hosp,"",Pfizer & BioNTech,Alpha,severe,hosp,,18,85,0.9,0.57,0.988,0,0,,13,16,severe,14.5,14.5,505&USA Mayo Clinic mixed hosp&Alpha&hosp&18&85,0.8,0.106632653061225,1.38629436111989,0.666454081632653,0.306235047481865
505,Puranik A,0,102,102,United States,USA Mayo Clinic mixed hosp,"",Pfizer & BioNTech,Alpha,severe,hosp,,18,85,0.87,0.57,0.975,0,0,,17,20,severe,18.5,18.5,505&USA Mayo Clinic mixed hosp&Alpha&hosp&18&85,0.77,0.103316326530612,1.20831120592453,0.583378467140668,0.311111111111111
505,Puranik A,0,102,102,United States,USA Mayo Clinic mixed hosp,"",Pfizer & BioNTech,Alpha,severe,hosp,,18,85,0.84,0.8,0.9965,0,0,,21,24,severe,22.5,22.5,505&USA Mayo Clinic mixed hosp&Alpha&hosp&18&85,0.74,0.0501275510204082,1.04596855518269,0.260538206966778,0.446644259055887
